Several studies indicated the efficacy and safety of anti-inflammatory cytokine drugs such as human TNF-α or IL-6 monoclonal antibodies for rheumatic diseases, such as RA [78,79]. The gene discussed is TNF; the disease is rheumatoid arthritis.